Supplier Concentration Due Diligence in M&A India 2026: Dependency, Margins & Deal Red Flags

Supplier concentration due diligence in M&A India is not simply a procurement review. For a buyer, investor or lender, dependence on a small number of vendors can affect normalized EBITDA, working-capital requirements, forecast reliability, business continuity and ultimately deal value. The diligence objective is to quantify that dependence, test whether commercial terms are sustainable and determine how quickly the target could replace a critical supplier if supply, price, credit or quality conditions change.

Supplier concentration due diligence in M&A India: what should be tested?

A robust review starts with supplier-level purchase data, but it should not stop at a top-10 percentage. The transaction team should reconcile procurement to the general ledger, inventory movements and cost of goods sold; identify sole-source or technically approved vendors; understand contracts and purchase-order terms; test price changes and rebates; review credit periods and advances; and assess alternative-source qualification time. The key question is whether reported margins and cash flows assume supplier economics that a new owner can actually preserve.

Why supplier concentration can change transaction economics

Concentration can create several deal effects. A dominant supplier may have bargaining power to raise prices after a change of control. A vendor may provide unusually long credit that flatters working capital. Related-party or promoter-linked procurement may not be arm’s length. A sole-source component may create shutdown risk. Conversely, a concentrated supplier base is not automatically negative when contracts, substitutes, pricing formulas and service levels are strong. Professional judgment should distinguish concentration from dependency.

Evidence from Indian offer documents

Public SEBI filings illustrate why the issue deserves transaction-level analysis. An April 2026 SEBI-filed document disclosed that the top 10 suppliers represented 90.66% of total purchases in one reported period and specifically identified supply disruption, pricing and credit-term risks. A 2025 SEBI-filed DRHP disclosed top-five supplier concentration of 38.54% and top-ten concentration of 54.25% for Fiscal 2025, while noting that much procurement was purchase-order based rather than under long-term contracts. These are issuer-specific disclosures, not universal thresholds for acceptable concentration.

Eight diligence tests for supplier dependency

• Build a supplier concentration bridge for the top 1, 3, 5 and 10 vendors across at least three historical periods and the latest available period.

• Reconcile supplier purchases to the purchase ledger, inventory records, cost of materials consumed and financial statements; investigate unexplained differences.

• Separate strategic sole-source vendors from suppliers that are concentrated merely because management consolidates volumes for better economics.

• Review contracts, purchase orders, minimum-volume commitments, termination rights, change-of-control provisions, exclusivity, price-reset clauses and service-level obligations.

• Compare unit prices, rebates, freight, quality claims and credit terms over time to identify margin support that may not be sustainable.

• Identify supplier advances, deposits, letters of credit, guarantees and unusual payable balances that may create debt-like or working-capital adjustments.

• Test alternative suppliers: technical approval, tooling, regulatory qualification, lead time, import dependence and realistic switching cost.

• Overlay related-party and promoter connections so that apparently commercial procurement is not accepted without arm’s-length analysis.

Worked M&A example: when concentration becomes a valuation issue

Assume a target reports ₹300 crore of annual purchases and its largest supplier accounts for ₹105 crore, or 35%. The supplier has historically granted 75-day credit, while credible alternatives offer 45 days and are 3% more expensive. If diligence indicates the existing terms are unlikely to continue after closing, two adjustments may be relevant. First, the buyer may normalize EBITDA for the sustainable procurement cost rather than capitalizing an unusually favorable historic margin. Second, the working-capital peg may need to reflect sustainable payable days rather than the target’s historical 75-day position. The numbers here are illustrative; an actual adjustment depends on contracts, market evidence and the SPA mechanism.

Supplier concentration and normalized EBITDA

Quality-of-earnings work should determine whether procurement savings are recurring. Temporary discounts, year-end rebates without supporting agreements, promoter-negotiated concessions, below-market related-party purchases, abnormal freight absorption or one-off commodity benefits can overstate maintainable EBITDA. The diligence report should show the reported result, proposed normalization, evidence and sensitivity rather than presenting a single unsupported adjustment.

Supplier concentration and working-capital normalization

Payables deserve particular attention. A target can show strong cash conversion because a few suppliers tolerate extended payment cycles. If those terms are relationship-driven, overdue, disputed or unlikely to transfer to the buyer, historical net working capital may understate the cash required to operate the business. Review ageing, subsequent payments, contractual credit days, debit balances, advances, overdue MSME exposures where relevant, and the treatment of supplier financing or reverse-factoring arrangements.

Red flags transaction teams should investigate

• A single vendor supplies a critical input with no technically approved substitute.

• Top-supplier concentration rises sharply while gross margin also improves without a documented commercial explanation.

• Large rebates or credit notes are booked near period end but supporting agreements are weak.

• Payables are materially beyond contractual terms and are being treated as ordinary working capital.

• Management says suppliers are replaceable, but qualification or tooling would take several months.

• Procurement from promoter-linked or related entities is material and benchmarking is absent.

• Supplier disputes, quality claims or delivery failures are excluded from management forecasts.

• Import dependence exposes the target to FX, logistics, sanctions, licensing or geopolitical disruption that is not reflected in forecast assumptions.

CFO and sell-side readiness checklist

Before opening a transaction data room, finance teams should prepare a clean vendor master, monthly supplier-level purchase analysis, contracts and major purchase orders, price and rebate history, payable ageing, subsequent-payment evidence, advances and deposits, quality claims, alternative-source analysis and related-party mapping. The supplier analysis should reconcile to audited or management financial information. Doing this early reduces repeated buyer queries and helps management explain genuine commercial concentration rather than allowing every high percentage to be treated as a red flag.

How supplier diligence connects with other financial due diligence

Supplier concentration should be read alongside inventory ageing, gross-margin trends, cash-flow quality, working-capital normalization and quality of earnings. PGT & Associates’ financial due diligence framework therefore treats procurement risk as part of the transaction economics rather than a standalone vendor checklist. Where supplier terms affect sustainable margins or closing working capital, the findings should flow into the normalized EBITDA and purchase-price analysis.

FAQs

Is a high top-10 supplier percentage automatically a deal red flag?

No. The percentage is a screening signal. Dependency depends on substitutability, contracts, pricing power, qualification lead time, supply security and the financial impact of switching.

Should supplier concentration affect valuation?

Potentially. If diligence demonstrates that current procurement pricing or credit terms are not sustainable, the effect may appear in normalized EBITDA, forecast cash flows, working-capital requirements or transaction protections. The valuation consequence should be evidence-based, not a mechanical concentration discount.

What period should be reviewed?

Typically, transaction teams benefit from several historical periods plus the latest available monthly or year-to-date data. The exact period depends on seasonality, commodity cycles, acquisitions and the nature of the business.

Does this replace legal or operational due diligence?

No. Financial diligence quantifies the economic exposure. Legal diligence should review enforceability and contractual rights, while operational specialists may be needed for technical qualification, manufacturing continuity or complex supply-chain risks.

Practical takeaway

The useful transaction question is not “What percentage comes from the top 10 suppliers?” It is “What happens to EBITDA, cash, continuity and purchase price if the relationship changes?” A strong supplier concentration due diligence analysis connects vendor dependency to sustainable earnings, working capital and the buyer’s downside case.

PGT & Associates supports transaction and financial due diligence, quality-of-earnings analysis, working-capital normalization and related advisory assignments. Scope and conclusions depend on the facts, records and professional requirements of each engagement.